NeuBase Therapeutics Inc (NASDAQ:NBSE)

8.01
Delayed Data
As of Aug 10
 +0.07 / +0.88%
Today’s Change
4.15
Today|||52-Week Range
11.78
+11.25%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for NeuBase Therapeutics Inc have a median target of 15.50, with a high estimate of 18.00 and a low estimate of 13.00. The median estimate represents a +93.51% increase from the last price of 8.01.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in NeuBase Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.23
Sales
$0.00
Reporting Date
Aug 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.82%
 
 
 
 
 
 
Growthannually 70.71%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.